UDK: УДК 616.248. – 085.357.- 053.2
N. V. Malyuzhinskaya, E. Y. Blinkova, O. V. Polyakova, D. N. Valmer
Кафедра детских болезней педиатрического факультета ВолгГМУ, кафедра клинической фармакологии и интенсивной терапии с курсами клинической фармакологии ФУВ, клинической аллергологии ФУВ
Step up therapy with fluticasone propionate (FP) in the regimen of medium doses can control the symptoms for a long time;it contributes to preserving low airway resistance during the treatment period in children 3 - 6 years old with mild to moderate persistent asthma. Combination therapy with low-dose FP and montelukast proved less effective than FP in the regimen of medium doses, but was superior to therapy with low doses of FP.
children, bronchial asthma, treatment, fluticasone propionate, montelukast.